Efficacy of Durvalumab in Non-muscle-invasive Bladder Cancer

NCT03759496 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

39

Enrollment

OTHER

Sponsor class

Conditions

Bladder Cancer

Interventions

BIOLOGICAL: Durvalumab

Sponsor

Hellenic GenitoUrinary Cancer Group